Global Nuclear Medicine/Radiopharmaceutic Professional Survey Report 2022, Forecast to 2027

Code: RW00014760589
Multimarket Insight
Aug-2022
Life Sciences
108 Pages

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Nuclear Medicine/Radiopharmaceutic industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Diagnostic
Therapeutic

Market Segment by Product Application
Oncology
Thyroid
Cardiology

Finally, the report provides detailed profile and data information analysis of leading company.
China Isotope & Radiation
Ciaeriar
Dongcheng
Jaco
Shanghai Atom Kexing
Advanced Molecular-imaging Solution

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Nuclear Medicine/Radiopharmaceutic consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Nuclear Medicine/Radiopharmaceutic market by identifying its various subsegments.
3.Focuses on the key global Nuclear Medicine/Radiopharmaceutic manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Nuclear Medicine/Radiopharmaceutic with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Nuclear Medicine/Radiopharmaceutic submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Nuclear Medicine/Radiopharmaceutic Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Nuclear Medicine/Radiopharmaceutic Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Nuclear Medicine/Radiopharmaceutic Segment by Type
2.1.1 Diagnostic
2.1.2 Therapeutic
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Thyroid
2.2.3 Cardiology
2.3 Global Nuclear Medicine/Radiopharmaceutic Market Comparison by Regions (2017-2027)
2.3.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (2017-2027)
2.3.2 North America Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.3 Europe Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.4 Asia-pacific Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.5 South America Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceutic Industry Impact
2.5.1 Nuclear Medicine/Radiopharmaceutic Business Impact Assessment - Covid-19
2.5.2 Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Nuclear Medicine/Radiopharmaceutic Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share
3.5 Top 10 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.7 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Nuclear Medicine/Radiopharmaceutic Industry Key Manufacturers
4.1 China Isotope & Radiation
4.1.1 Company Details
4.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 China Isotope & Radiation News
4.2 Ciaeriar
4.2.1 Company Details
4.2.2 Ciaeriar Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.2.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Ciaeriar News
4.3 Dongcheng
4.3.1 Company Details
4.3.2 Dongcheng Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.3.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Dongcheng News
4.4 Jaco
4.4.1 Company Details
4.4.2 Jaco Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.4.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Jaco News
4.5 Shanghai Atom Kexing
4.5.1 Company Details
4.5.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.5.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Shanghai Atom Kexing News
4.6 Advanced Molecular-imaging Solution
4.6.1 Company Details
4.6.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.6.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Advanced Molecular-imaging Solution News

5 Global Nuclear Medicine/Radiopharmaceutic Sales Categorized by Regions
5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue, Sales and Market Share by Regions
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Regions (2017-2022)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions (2017-2022)
5.2 North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
5.3 Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
5.5 South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)

6 North America Nuclear Medicine/Radiopharmaceutic Market Size Categorized by Countries
6.1 North America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
6.1.3 United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
6.1.4 Canada Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
6.1.5 Mexico Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
6.2 North America Nuclear Medicine/Radiopharmaceutic Revenue (Value) by Manufacturers
6.3 North America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2017-2022)
6.4 North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

7 Europe Nuclear Medicine/Radiopharmaceutic Market Size Categorized by Countries
7.1 Europe Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
7.1.3 Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.1.4 UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.1.5 France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.1.6 Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.1.7 Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.1.8 Spain Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
7.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue (Value) by Manufacturers
7.3 Europe Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2017-2022)
7.4 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

8 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size Categorized by Countries
8.1 Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
8.1.3 China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.1.4 South Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.1.5 Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.1.6 Australia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.1.7 India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue (Value) by Manufacturers
8.3 Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

9 South America Nuclear Medicine/Radiopharmaceutic Market Size Categorized by Countries
9.1 South America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Countries
9.1.1 South America Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
9.1.2 South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
9.1.3 Brazil Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
9.2 South America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2017-2022)
9.3 South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

10 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size Categorized by Countries
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
10.1.3 GCC Countries Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
10.1.4 Turkey Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
10.1.5 Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
10.1.6 South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

11 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Type
11.1 Global Nuclear Medicine/Radiopharmaceutic Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2017-2022)
11.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2017-2022)
11.2 Diagnostic Sales Growth Rate and Price
11.2.1 Global Diagnostic Sales Growth Rate (2017-2022)
11.2.2 Global Diagnostic Price (2017-2022)
11.3 Therapeutic Sales Growth Rate and Price
11.3.1 Global Therapeutic Sales Growth Rate (2017-2022)
11.3.2 Global Therapeutic Price (2017-2022)

12 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Application
12.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)
12.2 Oncology Sales Growth Rate (2017-2022)
12.3 Thyroid Sales Growth Rate (2017-2022)
12.4 Cardiology Sales Growth Rate (2017-2022)

13 Global Nuclear Medicine/Radiopharmaceutic Market Forecast
13.1 Global Nuclear Medicine/Radiopharmaceutic Revenue, Sales and Growth Rate (2022-2027)
13.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions (2022-2027)
13.2.1 North America Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
13.2.2 Europe Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
13.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
13.2.4 South America Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
13.2.5 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
13.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by Type (2022-2027)
13.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
13.3.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2022-2027)
13.4 Nuclear Medicine/Radiopharmaceutic Market Forecast by Application (2022-2027)
13.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
13.4.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Nuclear Medicine/Radiopharmaceutic Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Nuclear Medicine/Radiopharmaceutic
Figure Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Type
Figure Global Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2021
Figure Diagnostic Picture
Figure Therapeutic Picture
Table Global Nuclear Medicine/Radiopharmaceutic Market Size (Volume) by Application
Figure Oncology Picture
Figure Thyroid Picture
Figure Cardiology Picture
Table Global Nuclear Medicine/Radiopharmaceutic Comparison by Regions (M USD) 2017-2027
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size (Million US$) (2017-2027)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturer (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturer in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table Mergers & Acquisitions Planning
Table China Isotope & Radiation Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of China Isotope & Radiation
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of China Isotope & Radiation 2017-2022
Table China Isotope & Radiation Main Business
Table China Isotope & Radiation Recent Development
Table Ciaeriar Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Ciaeriar
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ciaeriar 2017-2022
Table Ciaeriar Main Business
Table Ciaeriar Recent Development
Table Dongcheng Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Dongcheng
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dongcheng 2017-2022
Table Dongcheng Main Business
Table Dongcheng Recent Development
Table Jaco Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Jaco
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Jaco 2017-2022
Table Jaco Main Business
Table Jaco Recent Development
Table Shanghai Atom Kexing Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Shanghai Atom Kexing
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Atom Kexing 2017-2022
Table Shanghai Atom Kexing Main Business
Table Shanghai Atom Kexing Recent Development
Table Advanced Molecular-imaging Solution Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Advanced Molecular-imaging Solution
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Advanced Molecular-imaging Solution 2017-2022
Table Advanced Molecular-imaging Solution Main Business
Table Advanced Molecular-imaging Solution Recent Development
Figure Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions in 2021
Figure North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2017-2022)
Figure North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2021
Table North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2017-2022)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2021
Figure United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Canada Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Mexico Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2021)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2021
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2021
Figure Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Spain Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2021)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2017-2022)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2021
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2021
Figure China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2021)
Figure Asia-pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table Asia-pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2017-2022)
Figure South America Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2017-2022)
Figure South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2019
Table South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2017-2022)
Figure South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2019
Figure Brazil Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table South America Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2017-2022)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2019
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2019
Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Turkey Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure South Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2019
Figure Global Diagnostic Sales Growth Rate (2017-2022)
Figure Global Diagnostic Price (2017-2022)
Figure Global Therapeutic Sales Growth Rate (2017-2022)
Figure Global Therapeutic Price (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2021
Figure Global Oncology Sales Growth Rate (2017-2022)
Figure Global Thyroid Sales Growth Rate (2017-2022)
Figure Global Cardiology Sales Growth Rate (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2022-2027)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Regions (2017-2022)
Figure North America Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Europe Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Asia-Pacific Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure South America Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Middle East & Africa Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

China Isotope & Radiation
Ciaeriar
Dongcheng
Jaco
Shanghai Atom Kexing
Advanced Molecular-imaging Solution

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE